ELVN Competitors & Alternatives
Compare Enliven Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ELVN
Main Stock$51.09
Tradestie Score
64
Market Cap
$1.17B
Analyst Upside
+29.2%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$131.42
|
$3.98B | - | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$83.58
|
$3.92B | - | 49 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$119.35
|
$3.91B | - | 59 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$20.49
|
$3.83B | - | 59 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$19.97
|
$3.68B | - | 56 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$122.13
|
$3.67B | - | 64 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.08
|
$3.59B | 13.6 | 61 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$26.22
|
$3.58B | 11.8 | 59 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$316.24
|
$3.49B | 41.0 | 66 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$11.14
|
$3.40B | - | 61 | Compare |
More ELVN Analysis
Data updated: Jul 11, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry